Dispelling Myths in the Value vs. Growth Debate
by Ben Inker, GMO LLC Executive Summary After several strong quarters for value stocks, the last few months…
Prepare, Don’t Predict: Building Resilient Portfolios with Private Credit
For decades, investors climbed the 60/40 ladder with confidence. Now, every step feels less steady. High inflation that refuses to budge, interest rates that won’t come down anytime soon, and the growing correlation between stocks and bonds...
Part 1: Inflation – Tall Tales and True Causes
by James Montier and Philip Pilkington, GMO LLC Executive Summary Inflation is often a poorly understood concept, with…
GMO: Quality Investing and Inflation
by Focused Equity Team, GMO LLC With inflation spiking as the world adjusts to the post-Covid regime, investors…
GMO: The Duration of Value and Growth
Much Closer to Each Other Than You’d Guess by Ben Inker, GMO LLC Executive Summary It is commonly…
GMO Quarterly: Uncertainty Has Seldom Been Higher
by Ben Inker and Jeremy Grantham, GMO LLC Uncertainty Has Seldom Been Higher Oddly, Neither Has the Stock…
GMO: Shelter in Credit
by Jon Roiter, Co-head of Credit Opportunities, GMO LLC Jon Roiter is co-Portfolio Manager of GMO’s Credit Opportunities…
Fear and the Psychology of Bear Markets
by James Montier, GMO Executive Summary While it is, of course, a cliché to say that markets are…
GMO: 60/40 Portfolios Face Double Trouble Ahead
by Rick Friedman, GMO LLC Executive Summary While the passive balanced portfolio (60% stock/40% bond) has outperformed more…
GMO's Ben Inker: "Shades of 2000"
by Ben Inker, Head of Asset Allocation, GMO GMO Quarterly Letter | 3Q 2019 Executive Summary The years…
GMO: Bigger's Been Better
by Ben Inker, Head of Asset Allocation, GMO LLC QUARTERLY LETTER 2Q 2019 EXECUTIVE SUMMARY The largest companies…
GMO: Emerging Value and Margin of Superiority
by Ben Inker, GMO LLC Emerging Value and Margin of Superiority Why would a value manager buy more…
GMO: Investment Outlook (May 2016)
GMO: Investment Outlook (May 2016) Keeping the Faith by Ben Inker and Jeremy Grantham, GMO LLC The past…
